Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Consumer Drugs

Set Alert for Consumer Drugs

It’s Complicated: Health Care Act Simplifies Buying OTCs With Pre-Tax Accounts

CHPA gives tempered support for White House-backed legislation to replace the Affordable Care Act because it would eliminate requirement that consumers can only use pre-tax savings accounts for OTCs if they have a prescription.

Consumer Legislation United States

Latest From Consumer

Singapore Eye Wash Maker Blinks At US FDA's OTC Monograph, GMPs

A warning FDA submitted March 16 says Opto-Pharm's "Buffered Eye & Skin" product – distributed in the US by Cintas under the Xpect and First Aid Direct brands – are not labeled or formulated in accordance with the agency's ophthalmic drug products monograph.

Singapore Asia Pacific

Hawaii's Proposed Oxybenzone Sunscreen Ban Fails Science Test – CHPA

CHPA commits to fighting against onslaught of bills in Hawaii aiming to ban or limit the use of oxybenzone-containing sunscreens, says CEO and President Scott Melville during his address on 2017 priorities during the CHPA Annual Executive Conference in Amelia Island, Fla. March 21.

United States Consumer

Alka-Seltzer Antacid Will 'Plop, Plop Fizz, Fizz' Without Aspirin

In advance of a US FDA advisory panel meeting on the safety of OTC monograph antacid/aspirin products, Bayer is removing aspirin from its pioneering Alka-Seltzer effervescent indigestion products. Bayer's Andre Schmidt talks about the safety advantages and consumer trends that helped spur the change.

Consumer Drug Safety

OTC Allergy Drugs: Not Just For Sniffles And Headaches, Sanofi Advises

The US office of Sanofi consumer division says 160 participants wore a wearable device for 30 days to track their sleep and activity. The 80 participants with allergies were less active and slept less.

Consumer Digital Health

OTC Allergy Drug Use Increases: A Symptom With Multiple Causes

CHPA says growing use of allergy OTCs from 2009 through 2015 in the US is a sign of more consumers prioritizing self-care over using health care services, but allergy specialists say their patients often have to start with an OTC even when they have a prescription.

Prescription To Otc Switch Respiratory

Consumer Health Weekly Trademark Review March 14, 2017

OTC drug, personal care product and nutritional supplement trademark filings compiled from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.

China India
See All